On September 10, 2020 BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, reported that the Company will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 at 11:45 a.m. ET (Press release, BeiGene, SEP 10, 2020, View Source/news-releases/news-release-details/beigene-present-morgan-stanley-18th-annual-global-healthcare" target="_blank" title="View Source/news-releases/news-release-details/beigene-present-morgan-stanley-18th-annual-global-healthcare" rel="nofollow">View Source [SID1234564965]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast can be accessed from the investors section of BeiGene’s website at View Source or View Source An archived replay will be available following the event for 90 days.

On September 10, 2020 DURECT Corporation (Nasdaq: DRRX) reported that it will participate in the HC Wainwright 22nd Annual Global Investment Conference, Cantor Fitzgerald Virtual Global Healthcare Conference and Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Press release, DURECT, SEP 10, 2020, https://investors.durect.com/news-releases/news-release-details/durect-corporation-participate-september-virtual-investor?field_nir_news_date_value[min]=2020 [SID1234564964]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

HC Wainwright 22nd Annual Global Investment Conference
Date Monday, September 14
Time: 2:30-2:50 PM EDT (Fireside Chat with Ed Arce)
Webcast: View Source

Cantor Fitzgerald Virtual Global Healthcare Conference
Date Tuesday, September 15
Time 10-10:30am EDT (Fireside Chat with Ellie Merle)
Webcast: View Source

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Tuesday, September 22
Time: 11:40am-12:20pm EDT (Fireside chat with Francois Brisebois)
Webcast: View Source

On September 10, 2020 TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., reported that Charles Theuer, M.D., Ph.D., President and CEO, will present a corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16th, at 12:00 pm EDT (Press release, Tracon Pharmaceuticals, SEP 10, 2020, View Source [SID1234564963]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access a live webcast of the presentation, please visit the "Events and Presentations" page within the "Investors" section of the TRACON Pharmaceuticals website at www.traconpharma.com. A replay of the webcast will also be available following the event.

On September 10, 2020 Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, reported that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in three virtual investor conferences in September 2020 (Press release, Mustang Bio, SEP 10, 2020, View Source [SID1234564961]). The company will also host virtual one-on-one meetings during the conferences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the events are as follows:

H.C. Wainwright 22nd Annual Global Investment Conference: Presentation on Monday, September 14, 2020, at 2:30 p.m. EDT
Cantor Virtual Global Healthcare Conference: Fireside Chat on Wednesday, September 16, 2020, at 2:00 p.m. EDT
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: Fireside Chat on Monday, September 21, 2020, at 3:20 p.m. EDT
Live webcasts of the presentation and fireside chats will be available on the Events page of the Investors Relations section of Mustang’s website: www.mustangbio.com. Archived replays of the webcasts will be available for approximately 30 days following each presentation and fireside chat.

On September 10, 2020 Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, reported that James F. Oliviero, President and Chief Executive Officer, will participate in three virtual investor conferences in September 2020 (Press release, Checkpoint Therapeutics, SEP 10, 2020, View Source [SID1234564960]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the events are as follows:

H.C. Wainwright 22nd Annual Global Investment Conference: Presentation on Monday, September 14, 2020, at 3:30 p.m. EDT
Cantor Virtual Global Healthcare Conference: Presentation on Wednesday, September 16, 2020, at 10:00 a.m. EDT
Lake Street Capital Markets 4th Annual Best Ideas Growth (BIG4) Conference: Virtual one-on-one meetings on Thursday, September 17, 2020
Webcasts of the presentations will be available on the Events page, located within the Investors section of Checkpoint’s website, View Source, for approximately 30 days following each presentation.